Welcome to ActionLyme - the Lyme Cryme Whistleblower's Website

Borreliosis Basics (poster) ALDF/CDC Patents USDOJ RICO Complaint AIDS-like EBV-Borreliosis; UN Complaint (2003) Bioweapons Attributes Khan Acad of Cryme
Lyme Facts (poster) CDC's Patents w/ GSK Blumenthal (AntiTrust) Sepsis & Autism, 20 reports Antics Crazy Eddy & Durl Lyme as a bioweapon? 5 new "Axes" DSM
Persistence: Historical, IDSA's UConn Assaults Children 20 reports; Sepsis, Autism OspA / Pam3Cys Tolerance Mark Klempner's Crymes Army says Bioweapon DCF witnesses demonic
Crooks' DNA Shell Game Congenital Lyme by Yale Dattwyler: Seronegative Lyme Failed Other Fungal Vaccines Munchausen's Accusations Russians@NYMC (HLAs) 141215homepage
Steere Falsifies test Halperin: Lyme & ALS Steere: Seronegative Lyme PubMed: OspA activates EBV McSweegan Munchausen's Plum Island Evidence Cryme Trainer 2012
Yale's Lyme Vaccine Scam Steere: Lyme causes Lupus Klempner on hidden tape LYMErix causes neuro disease ALDF.com files Jan-Nov 2014 home
IDSA's & CDC Biomarkers Klempner & "Guidelines" False Claims Act referenced NIH:  CLD is active herpes Fish @ Internat.Spy Firm
Plum Stupid, referenced New Cryme Disease Videos .

ME/CFS is active herpes


01/22/2015 20:19:43

Home

A-L Navigation


Cryme Disease video playlist

Cryme Disease
Norway Site


Bad Ass Cryme Blog

Lyme-Cryme.com


141219_post-sepsis Rituximab (again)

Pandora: ME/CFS related to AutismVaccines
 



Follow the Lyme/LYMErix Scam in the order it occurred, below:

Older data on the incurability of Relapsing Fever

1986, McSweegan trashes Navy for $$$ for ALDF.com

1988, Dattwyler & about immune-suppressing, seronegative Lyme

1990, CDC: "Diagnose Lyme as if it was Relapsing Fever."   

Allen Steere  "NeuroLyme won't test positive," 1990.

1992, CDC officer Allen Steere falsifies testing in Europe

1992, CDC patents with SmithKline show 2 kinds of Lyme

1993, Barbour and Fish slam Neurologic Lyme victims.

Compare the 2 kinds of Lyme in the RICO complaint

1994, FDA LYMErix Meeting

1994, CDC's Dearborn Booklet .pdf

CDC's invitation to participate in Dearborn .pdf

Dearborn, Who Said What?

Igenex, Harris, Dearborn .pdf

Evidence  Lyme criminals knew LYMErix produced the same "multisystem disease" as "Chronic Lyme"

LYMErix Damage Coverup (short)
 

1998, CIA Oilmen & Israelis plan to overthrow Saddam for the oil.

ActionLyme/Kathleen Dickson predicts all of Bushie's outcomes in Oct 2000

ActionLyme/Kathleen Dickson predicts Bush will have us worshipping his bombs (Shock and Awe"), in Oct 2000 during the Gore Debates    



Steere's "Seronegative Lyme" Hysteria about OspA-induced Antibody Inhibition
Read about it also in the 1998 FDA LYMErix meeting transcript:
http://www.fda.gov/ohrms/dockets/ac/98/transcpt/3422t1.rtf


1990
; Steere using Dattwyler and Volkman's Seronegative Lyme Assay (developed because Dattwyler knew fungal antigens produced immunosuppression) to evaluate "Chronic Neurologic Lyme" cases:


http://www.nejm.org/doi/pdf/10.1056/NEJM199011223232102


See Also, CRYMEDISEASE_CHP3_B.htm  where we show Steere in 1991 actually used this seronegative Lyme assay on his own lab
workers, 101016.htm (
http://www.ncbi.nlm.nih.gov/pubmed/1883122)  where we see Steere knowingly falsely advising the Academy
of Insurance Medicine a year later (1992), and the Plum Island Chapter of Cryme Disease where Justin Radolf demonstrates in 2001
that OspA vaccination (or autovaccination via blebbing), results in inhibition of antibody production via downregulation of HLA.

N  1988 Dec 1;319(22):1441-6.

Seronegative Lyme disease. Dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi.

Source

Department of Medicine, State University of New York, School of Medicine, Stony Brook 11794-8161.

Abstract

The diagnosis of Lyme disease often depends on the measurement of serum antibodies to Borrelia burgdorferi, the spirochete that causes this disorder. Although prompt treatment with antibiotics may abrogate the antibody response to the infection, symptoms persist in some patients. We studied 17 patients who had presented with acute Lyme disease and received prompt treatment with oral antibiotics, but in whom chronic Lyme disease subsequently developed. Although these patients had clinically active disease, none had diagnostic levels of antibodies to B. burgdorferi on either a standard enzyme-linked immunosorbent assay or immunofluorescence assay. On Western blot analysis, the level of immunoglobulin reactivity against B. burgdorferi in serum from these patients was no greater than that in serum from normal controls. The patients had a vigorous T-cell proliferative response to whole B. burgdorferi, with a mean ( +/- SEM) stimulation index of 17.8 +/- 3.3, similar to that (15.8 +/- 3.2) in 18 patients with chronic Lyme disease who had detectable antibodies. The T-cell response of both groups was greater than that of a control group of healthy subjects (3.1 +/- 0.5; P less than 0.001). We conclude that the presence of chronic Lyme disease cannot be excluded by the absence of antibodies against B. burgdorferi and that a specific T-cell blastogenic response to B. burgdorferi is evidence of infection in seronegative patients with clinical indications of chronic Lyme disease.

Comment in

http://www.ncbi.nlm.nih.gov/pubmed/3054554